{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:13:30Z","timestamp":1784740410620,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan province","doi-asserted-by":"publisher","award":["(Grant Number: 242300420093)."],"award-info":[{"award-number":["(Grant Number: 242300420093)."]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08200-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:05:03Z","timestamp":1779372303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["METTL3-dependent m6A-modified circ_0026652 facilitates immune evasion of diffuse large B-cell lymphoma cells by inhibiting CD8+ T-cell responses"],"prefix":"10.1186","volume":"24","author":[{"given":"Xue","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"1","key":"8200_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74\u201387.","journal-title":"Pathology"},{"issue":"1","key":"8200_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12672-025-01958-w","volume":"16","author":"A Berhan","year":"2025","unstructured":"Berhan A, Almaw A, Damtie S, Solomon Y. Diffuse large B cell lymphoma (DLBCL): epidemiology, pathophysiology, risk stratification, advancement in diagnostic approaches and prospects: narrative review. Discov Oncol. 2025;16(1):184.","journal-title":"Discov Oncol"},{"issue":"1","key":"8200_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13353-023-00804-5","volume":"65","author":"HA Almasmoum","year":"2024","unstructured":"Almasmoum HA. Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications. J Appl Genet. 2024;65(1):57\u201372.","journal-title":"J Appl Genet"},{"key":"8200_CR4","doi-asserted-by":"crossref","unstructured":"Fangazio M, Ladewig E, Gomez K, Garcia-Ibanez L, Kumar R, Teruya-Feldstein J, Rossi D, Filip I, Pan-Hammarstrom Q, Inghirami G, et al. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proc Natl Acad Sci USA. 2021;118(22).","DOI":"10.1073\/pnas.2104504118"},{"key":"8200_CR5","doi-asserted-by":"crossref","unstructured":"Abrisqueta P. New insights into first-line therapy in diffuse large B-Cell lymphoma: are we improving outcomes? J Clin Med. 2024;13(7).","DOI":"10.3390\/jcm13071929"},{"issue":"6","key":"8200_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood.2023023419","volume":"144","author":"J Kim","year":"2024","unstructured":"Kim J, Cho J, Lee MH, Yoon SE, Kim WS, Kim SJ. CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis. Blood. 2024;144(6):629\u201338.","journal-title":"Blood"},{"issue":"3","key":"8200_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"key":"8200_CR8","doi-asserted-by":"crossref","unstructured":"Sun M, Yang Y. Biological functions and applications of circRNAs-next generation of RNA-based therapy. J Mol Cell Biol. 2023;15(5).","DOI":"10.1093\/jmcb\/mjad031"},{"key":"8200_CR9","doi-asserted-by":"crossref","unstructured":"Golovina E, Eaton C, Cox V, Andel J, Savvulidi Vargova K. Mechanism of action of circRNA\/miRNA Network in DLBCL. Noncoding RNA. 2025;11(2).","DOI":"10.3390\/ncrna11020022"},{"issue":"9","key":"8200_CR10","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/cdd.2017.86","volume":"24","author":"Q Yang","year":"2017","unstructured":"Yang Q, Du WW, Wu N, Yang W, Awan FM, Fang L, Ma J, Li X, Zeng Y, Yang Z, et al. A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell Death Differ. 2017;24(9):1609\u201320.","journal-title":"Cell Death Differ"},{"issue":"19","key":"8200_CR11","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.18632\/aging.102122","volume":"11","author":"Y Hu","year":"2019","unstructured":"Hu Y, Zhao Y, Shi C, Ren P, Wei B, Guo Y, Ma J. A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt\/beta-catenin signaling via interacting with TET1 and miR-888. Aging. 2019;11(19):8068\u201384.","journal-title":"Aging"},{"issue":"8","key":"8200_CR12","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/cas.15402","volume":"113","author":"L Dong","year":"2022","unstructured":"Dong L, Huang J, Gao X, Du J, Wang Y, Zhao L. CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a\/b to disinhibit PD-L1. Cancer Sci. 2022;113(8):2888\u2013903.","journal-title":"Cancer Sci"},{"issue":"6","key":"8200_CR13","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1007\/s11010-024-05186-8","volume":"480","author":"M Sanati","year":"2025","unstructured":"Sanati M, Ghafouri-Fard S. Circular RNAs: key players in tumor immune evasion. Mol Cell Biochem. 2025;480(6):3267\u201395.","journal-title":"Mol Cell Biochem"},{"key":"8200_CR14","doi-asserted-by":"crossref","unstructured":"Zhou M, Chen M, Zheng Z, Li Q, Liao L, Wang Y, Xu Y, Shu G, Luo J, Yang T, et al. CircRNA GRAMD4 induces NBR1 expression to promote autophagy and immune escape in renal cell carcinoma. Autophagy. 2025:1\u201321.","DOI":"10.1080\/15548627.2025.2503560"},{"key":"8200_CR15","doi-asserted-by":"publisher","first-page":"217639","DOI":"10.1016\/j.canlet.2025.217639","volume":"620","author":"J Li","year":"2025","unstructured":"Li J, Xu S, Zhan Y, Lv X, Sun Z, Man L, Yang D, Sun Y, Ding S. CircRUNX1 enhances the Warburg effect and immune evasion in non-small cell lung cancer through the miR-145\/HK2 pathway. Cancer Lett. 2025;620:217639.","journal-title":"Cancer Lett"},{"issue":"8","key":"8200_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00109-024-02463-3","volume":"102","author":"MA Ortega","year":"2024","unstructured":"Ortega MA, Boaru DL, De Leon-Oliva D, Fraile-Martinez O, Garcia-Montero C, Rios L, Garrido-Gil MJ, Barrena-Blazquez S, Minaya-Bravo AM, Rios-Parra A, et al. PD-1\/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications. J Mol Med (Berl). 2024;102(8):987\u20131000.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"8200_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41420-024-02197-8","volume":"10","author":"L Liang","year":"2024","unstructured":"Liang L, Gao M, Li W, Tang J, He Q, Zeng F, Cao J, Liu S, Chen Y, Li X, et al. CircGSK3beta mediates PD-L1 transcription through miR-338-3p\/PRMT5\/H3K4me3 to promote breast cancer cell immune evasion and tumor progression. Cell Death Discov. 2024;10(1):426.","journal-title":"Cell Death Discov"},{"issue":"2","key":"8200_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-023-05570-0","volume":"14","author":"H Guan","year":"2023","unstructured":"Guan H, Tian K, Luo W, Li M. m(6)A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m(6)A\/PD-L1 manner. Cell Death Dis. 2023;14(2):120.","journal-title":"Cell Death Dis"},{"issue":"8002","key":"8200_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41586-024-07060-5","volume":"627","author":"LH Ngo","year":"2024","unstructured":"Ngo LH, Bert AG, Dredge BK, Williams T, Murphy V, Li W, Hamilton WB, Carey KT, Toubia J, Pillman KA, et al. Nuclear export of circular RNA. Nature. 2024;627(8002):212\u201320.","journal-title":"Nature"},{"issue":"1","key":"8200_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2018.1557498","volume":"16","author":"Z Li","year":"2019","unstructured":"Li Z, Kearse MG, Huang C. The nuclear export of circular RNAs is primarily defined by their length. RNA Biol. 2019;16(1):1\u20134.","journal-title":"RNA Biol"},{"issue":"8","key":"8200_CR21","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4049\/jimmunol.2300761","volume":"212","author":"J Liu","year":"2024","unstructured":"Liu J, Shao Y, Li C. YTHDC1\/CRM1 Facilitates m6A-Modified circRNA388 Nuclear Export to Induce Coelomocyte Autophagy via the miR-2008\/ULK Axis in Apostichopus japonicus. J Immunol. 2024;212(8):1319\u201333.","journal-title":"J Immunol"},{"issue":"10","key":"8200_CR22","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8200_CR23","doi-asserted-by":"crossref","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, Sha J, Huang X, Guerrero L, Xie P, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. 2017;6.","DOI":"10.7554\/eLife.31311"},{"issue":"1","key":"8200_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s11658-023-00515-z","volume":"28","author":"M Song","year":"2023","unstructured":"Song M, Yao H, Sun Z, Chen D, Xu X, Long G, Wu L, Hu W. METTL3\/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. Cell Mol Biol Lett. 2023;28(1):101.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"8200_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.gendis.2019.12.002","volume":"8","author":"RZ He","year":"2021","unstructured":"He RZ, Jiang J, Luo DX. M6A modification of circNSUN2 promotes colorectal liver metastasis. Genes Dis. 2021;8(1):6\u20137.","journal-title":"Genes Dis"},{"issue":"21","key":"8200_CR26","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1182\/bloodadvances.2021004203","volume":"5","author":"B Manfroi","year":"2021","unstructured":"Manfroi B, De Grandis M, Moreaux J, Tabruyn S, Mayol JF, Quintero M, Righini C, Sturm N, Aurrand-Lions M, Huard B. The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5. Blood Adv. 2021;5(21):4338\u201351.","journal-title":"Blood Adv"},{"issue":"1","key":"8200_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-025-07843-2","volume":"16","author":"Y Fang","year":"2025","unstructured":"Fang Y, Cheng L, Huang M, Cao Y, Zou Q, Cai J, Zhang Y, Xia Y, Huang H, Chen X, et al. Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair. Cell Death Dis. 2025;16(1):533.","journal-title":"Cell Death Dis"},{"issue":"6","key":"8200_CR28","doi-asserted-by":"publisher","first-page":"107641","DOI":"10.1016\/j.celrep.2020.107641","volume":"31","author":"G Di Timoteo","year":"2020","unstructured":"Di Timoteo G, Dattilo D, Centron-Broco A, Colantoni A, Guarnacci M, Rossi F, Incarnato D, Oliviero S, Fatica A, Morlando M, et al. Modulation of circRNA Metabolism by m(6)A Modification. Cell Rep. 2020;31(6):107641.","journal-title":"Cell Rep"},{"issue":"10","key":"8200_CR29","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"8200_CR30","doi-asserted-by":"publisher","first-page":"D327","DOI":"10.1093\/nar\/gkx934","volume":"46","author":"JJ Xuan","year":"2018","unstructured":"Xuan JJ, Sun WJ, Lin PH, Zhou KR, Liu S, Zheng LL, Qu LH, Yang JH. RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data. Nucleic Acids Res. 2018;46(D1):D327\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"8200_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016;63(2):306\u201317.","journal-title":"Mol Cell"},{"issue":"1","key":"8200_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41420-022-01040-2","volume":"8","author":"H Yan","year":"2022","unstructured":"Yan H, Zhang L, Cui X, Zheng S, Li R. Roles and mechanisms of the m(6)A reader YTHDC1 in biological processes and diseases. Cell Death Discov. 2022;8(1):237.","journal-title":"Cell Death Discov"},{"key":"8200_CR33","doi-asserted-by":"crossref","unstructured":"Xiao J, Joseph S, Xia M, Teng F, Chen X, Huang R, Zhai L, Deng W. Circular RNAs acting as miRNAs\u2019 sponges and their roles in stem cells. J Clin Med. 2022;11(10).","DOI":"10.3390\/jcm11102909"},{"issue":"4","key":"8200_CR34","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","volume":"46","author":"Z Lin","year":"2012","unstructured":"Lin Z, Yang H, Kong Q, Li J, Lee SM, Gao B, Dong H, Wei J, Song J, Zhang DD, et al. USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development. Mol Cell. 2012;46(4):484\u201394.","journal-title":"Mol Cell"},{"issue":"8","key":"8200_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139.","journal-title":"Cell Res"},{"issue":"1","key":"8200_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12964-020-00612-y","volume":"18","author":"Y Wang","year":"2020","unstructured":"Wang Y, Sun Q, Mu N, Sun X, Wang Y, Fan S, Su L, Liu X. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells. Cell Commun Signal. 2020;18(1):112.","journal-title":"Cell Commun Signal"},{"issue":"23","key":"8200_CR37","doi-asserted-by":"publisher","first-page":"e70239","DOI":"10.1111\/jcmm.70239","volume":"28","author":"S Chen","year":"2024","unstructured":"Chen S, Hu X, Yi X, Deng X, Xiong T, Ou Y, Liu S, Li C, Yan X, Hao L. USP22 Promotes Osteosarcoma Progression by Stabilising beta-Catenin and Upregulating HK2 and Glycolysis. J Cell Mol Med. 2024;28(23):e70239.","journal-title":"J Cell Mol Med"},{"key":"8200_CR38","doi-asserted-by":"crossref","unstructured":"Du L, Lee JH, Jiang H, Wang C, Wang S, Zheng Z, Shao F, Xu D, Xia Y, Li J, et al. beta-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion. J Exp Med. 2020;217(11).","DOI":"10.1084\/jem.20191115"},{"issue":"4","key":"8200_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3892\/ijo.2014.2531","volume":"45","author":"Z Ning","year":"2014","unstructured":"Ning Z, Wang A, Liang J, Xie Y, Liu J, Feng L, Yan Q, Wang Z. USP22 promotes the G1\/S phase transition by upregulating FoxM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma. Int J Oncol. 2014;45(4):1594\u2013608.","journal-title":"Int J Oncol"},{"issue":"2","key":"8200_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/onco.13610","volume":"26","author":"M Di","year":"2021","unstructured":"Di M, Huntington SF, Olszewski AJ. Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. Oncologist. 2021;26(2):120\u201332.","journal-title":"Oncologist"},{"issue":"16","key":"8200_CR41","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, Link BK, Hay A, Cerhan JR, Zhu L, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800\u20138.","journal-title":"Blood"},{"key":"8200_CR42","doi-asserted-by":"crossref","unstructured":"Song MK, Park BB, Uhm J. Understanding immune evasion and therapeutic targeting associated with PD-1\/PD-L1 pathway in diffuse large B-cell lymphoma. Int J Mol Sci. 2019;20(6).","DOI":"10.3390\/ijms20061326"},{"issue":"6","key":"8200_CR43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41423-020-0387-x","volume":"17","author":"A Paramasivam","year":"2020","unstructured":"Paramasivam A, Vijayashree Priyadharsini J. Novel insights into m6A modification in circular RNA and implications for immunity. Cell Mol Immunol. 2020;17(6):668\u20139.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8200_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, Liu J, Sun Z. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):105.","journal-title":"Mol Cancer"},{"issue":"1","key":"8200_CR45","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12967-024-05500-4","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu F, Gu W, Shao Y. Cross-talk between circRNAs and m6A modifications in solid tumors. J Transl Med. 2024;22(1):694.","journal-title":"J Transl Med"},{"issue":"6","key":"8200_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s13258-021-01094-z","volume":"43","author":"W Liu","year":"2021","unstructured":"Liu W, Lei L, Liu X, Ye S. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p. Genes Genomics. 2021;43(6):653\u201367.","journal-title":"Genes Genomics"},{"key":"8200_CR47","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.2147\/CMAR.S263222","volume":"12","author":"X Chen","year":"2020","unstructured":"Chen X, Xie X, Zhou W. CircCFL1\/MiR-107 Axis Targeting HMGB1 Promotes the Malignant Progression of Diffuse Large B-Cell Lymphoma Tumors. Cancer Manag Res. 2020;12:9351\u201362.","journal-title":"Cancer Manag Res"},{"key":"8200_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3389\/fgene.2020.00955","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Fu Y, Wang Y, Wang J. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. Front Genet. 2020;11:955.","journal-title":"Front Genet"},{"key":"8200_CR49","doi-asserted-by":"crossref","unstructured":"Alsaadi M, Khan MY, Dalhat MH, Bahashwan S, Khan MU, Albar A, Almehdar H, Qadri I. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis. Diagnostics (Basel). 2021; 11(10).","DOI":"10.3390\/diagnostics11101739"},{"issue":"12","key":"8200_CR50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41408-017-0033-8","volume":"7","author":"SK Leivonen","year":"2017","unstructured":"Leivonen SK, Icay K, Jantti K, Siren I, Liu C, Alkodsi A, Cervera A, Ludvigsen M, Hamilton-Dutoit SJ, d\u2019Amore F, et al. MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(12):654.","journal-title":"Blood Cancer J"},{"key":"8200_CR51","doi-asserted-by":"publisher","first-page":"735855","DOI":"10.3389\/fcell.2021.735855","volume":"9","author":"W Zheng","year":"2021","unstructured":"Zheng W, Lai G, Lin Q, Issah MA, Fu H, Shen J. A miR-129-5P\/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1\/PD-L1 Checkpoint. Front Cell Dev Biol. 2021;9:735855.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"8200_CR52","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41419-019-1886-5","volume":"10","author":"L Zhao","year":"2019","unstructured":"Zhao L, Liu Y, Zhang J, Liu Y, Qi Q. LncRNA SNHG14\/miR-5590-3p\/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1\/PD-L1 checkpoint. Cell Death Dis. 2019;10(10):731.","journal-title":"Cell Death Dis"},{"key":"8200_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-13-1426-1_6","volume":"1087","author":"AC Panda","year":"2018","unstructured":"Panda AC. Circular RNAs Act as miRNA Sponges. Adv Exp Med Biol. 2018;1087:67\u201379.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"8200_CR54","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.3390\/curroncol29090525","volume":"29","author":"J Ma","year":"2022","unstructured":"Ma J, Wen X, Xu Z, Xia P, Jin Y, Lin J, Qian J. The Down-Regulation of Circ_0059707 in Acute Myeloid Leukemia Promotes Cell Growth and Inhibits Apoptosis by Regulating miR-1287-5p. Curr Oncol. 2022;29(9):6688\u201399.","journal-title":"Curr Oncol"},{"issue":"1","key":"8200_CR55","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-019-1104-5","volume":"21","author":"D Schwarzenbacher","year":"2019","unstructured":"Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, et al. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019;21(1):20.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"8200_CR56","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12957-025-04032-5","volume":"23","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang J, Zhang M, Zhao W, Wu H, Wang R. miR-1287-5p suppresses proliferation, migration, invasion and promotes apoptosis in gastric cancer cells through targeting LAMTOR3. World J Surg Oncol. 2025;23(1):370.","journal-title":"World J Surg Oncol"},{"key":"8200_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2021.05.004","volume":"514","author":"T Feng","year":"2021","unstructured":"Feng T, Ling S, Xu C, Ying L, Su D, Xu X. Ubiquitin-specific peptidase 22 in cancer. Cancer Lett. 2021;514:30\u20137.","journal-title":"Cancer Lett"},{"key":"8200_CR58","doi-asserted-by":"publisher","first-page":"918314","DOI":"10.3389\/fimmu.2022.918314","volume":"13","author":"J Guo","year":"2022","unstructured":"Guo J, Zhao J, Fu W, Xu Q, Huang D. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms. Front Immunol. 2022;13:918314.","journal-title":"Front Immunol"},{"issue":"4","key":"8200_CR59","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1159\/000489156","volume":"46","author":"S Jiang","year":"2018","unstructured":"Jiang S, Song C, Gu X, Wang M, Miao D, Lv J, Liu Y. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt\/beta-Catenin Pathway. Cell Physiol Biochem. 2018;46(4):1412\u201322.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"8200_CR60","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/jcmm.13968","volume":"23","author":"S Jiang","year":"2019","unstructured":"Jiang S, Miao D, Wang M, Lv J, Wang Y, Tong J. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22\/Wnt\/beta-catenin signaling axis. J Cell Mol Med. 2019;23(1):630\u201340.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"8200_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","volume":"19","author":"H Yamaguchi","year":"2022","unstructured":"Yamaguchi H, Hsu JM, Yang WH, Hung MC. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol. 2022;19(5):287\u2013305.","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"8200_CR62","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","volume":"126","author":"J Kiyasu","year":"2015","unstructured":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, Sugita Y, Yufu Y, Choi I, Abe Y, et al. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015;126(19):2193\u2013201.","journal-title":"Blood"},{"issue":"7","key":"8200_CR63","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41423-019-0348-4","volume":"17","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang X, Bai X, Liang T. Blocking PD-L1 for anti-liver cancer immunity: USP22 represents a critical cotarget. Cell Mol Immunol. 2020;17(7):677\u20139.","journal-title":"Cell Mol Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08200-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08200-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:07:43Z","timestamp":1782479263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08200-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8200"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08200-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of The Affiliated Cancer Hospital of Zhengzhou University approved the study involving patient specimens. It was performed in accordance with the Declaration of Helsinki. All animal procedures adhered to the ARRIVE guidelines and received approval from the Institutional Animal Ethical Committee of The Affiliated Cancer Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"824"}}